Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-25-010474

CHIEF OPERATING OFFICER sold 6,667 shares at an average $18.04 ($120,269)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-07 Sale : show line 1 in the form 10b5-1 −3,756 $17.81 $66,889 319,554 I
2025-04-07 Sale : show line 2 in the form 10b5-1 −2,763 $18.29 $50,527 316,791 I
2025-04-07 Sale : show line 3 in the form 10b5-1 −148 $19.27 $2,852 316,643 I
Open-market sales · 6,667 sh · avg $18.04 · $120,269
Loading xslF345X05/form4-04092025_080436.xml…